EMA Recommends Dropping Tecovirimat for Mpox

The decision was based on results of clinical trials suggesting its lack of effectiveness for mpox.
Medscape News Europe

Source link : https://www.medscape.com/viewarticle/ema-recommends-dropping-tecovirimat-mpox-2026a10009gq?src=rss

Author :

Publish date : 2026-03-27 14:08:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

EMA Recommends Dropping Tecovirimat for Mpox

Concerning COVID Variant Shows Up in 29 States

AI data centres can warm surrounding areas by up to 9.1°C

Related Posts

Two Resuscitation Fluids Led to Similar Outcomes in Kids With Septic Shock

AOC vs RFK Jr. Memes; Are Doctors OK? Communicating With Gen Z Patients

‘Ozempic Personality’: Is Emotional Flattening Another Side Effect of GLP-1s?

Omalizumab Plus Immunotherapy May Ease Allergic Asthma

First Gene Therapy Approved for Hearing Loss

Think Heart Attacks Cause Most Sudden Cardiac Deaths? Think Again, Study Says

Two Resuscitation Fluids Led to Similar Outcomes in Kids With Septic Shock

AOC vs RFK Jr. Memes; Are Doctors OK? Communicating With Gen Z Patients

‘Ozempic Personality’: Is Emotional Flattening Another Side Effect of GLP-1s?

Omalizumab Plus Immunotherapy May Ease Allergic Asthma

First Gene Therapy Approved for Hearing Loss

Think Heart Attacks Cause Most Sudden Cardiac Deaths? Think Again, Study Says

FDA, CMS to Launch Speedy Coverage Pathway for Breakthrough Medical Devices

DMR Slows Post-Tirzepatide Weight Regain

Categories

Archives